Etubics - Crunchbase Company Profile & Funding

Q: Where is Etubics's headquarters?

Etubics is located in Seattle, Washington, United States.

Q: Who invested in Etubics?

Etubics is funded by National Institutes of Health.

Q: When was the last funding round for Etubics?

Etubics closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Etubics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Etubics

CB Rank

526149

Biopharmaceutical company. developing targeted immunotherapies and vaccine products for a wide range of resilient diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Seattle, Washington, United States

11-50

etubics.com

Biotechnology

Health Care

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Elizabeth S. Gabitzsch: Vice President & Research
Frank R. Jones: Founder ,President, Chief Scientific Officer & CEO

Details

Legal Name

Etubics Corporation

Operating Status

Active

Company Type

For Profit

Founders

Frank R. Jones

About the Company

Etubics Corporation is a Seattle based biopharmaceutical company developing targeted immunotherapies and vaccine products for a wide range of resilient diseases. Etubics patent-protected technology has been proven to be safer, more efficient and more effective than current vectored vaccines and gene delivery platforms.

Phone Number

2068382978

Contact Email

general@etubics.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Anktiva (N-803)

An investigational IL-15 superagonist complex designed to stimulate the immune system by enhancing the activity of natural killer (NK) and T cells.

PD-L1 t-haNK

A bioengineered NK cell therapy targeting PD-L1 with a chimeric antigen receptor (CAR) for cancer treatment, incorporating a high-affinity CD16 receptor to enhance antibody-mediated killing.

Research & Development

Etubics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Etubics	1	obfuscated obfuscation	National Institutes of Health	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
National Institutes of Health	Yes	Venture Round - Etubics	—
National Institutes of Health	Yes	Venture Round - Etubics	—
National Institutes of Health	Yes	Venture Round - Etubics	—
National Institutes of Health	Yes	Venture Round - Etubics	—
National Institutes of Health	Yes	Venture Round - Etubics	—